Hyundai Bioscience현대바이오
048410 · KOSDAQ · ₩048410 · 현대바이오
₩5,820▼ ₩120 (2.02%)End-of-day · Oct 27, 2026 · End-of-day prices.
Filings
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Oct 23, 2026Open on DART
Predicted impact: Low
- Shareholders' meeting called주주총회소집결의 (임시주주총회)Oct 23, 2026Open on DART
Predicted impact: Low
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 13, 2026Open on DART
Predicted impact: Low· Actual: +10.2% vs sector, volume 0.5× normal (5 trading days)
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 13, 2026Open on DART
Predicted impact: Low· Actual: +10.2% vs sector, volume 0.5× normal (5 trading days)
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Oct 2, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 16, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 16, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 8, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인 신청)Sep 4, 2026Open on DART
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 6, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 30, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jun 23, 2026Open on DART
- Major Matters Report (Exercise of Convertible Bond Call Option Designation)주요사항보고서(전환사채매수선택권행사자지정)Jun 23, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 19, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jun 15, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 12, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)May 29, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 23, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인)Apr 17, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Mar 30, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 26, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Audit report submitted감사보고서제출Mar 17, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인 신청)Mar 6, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 6, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 25, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 20, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Feb 13, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 23, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 19, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 19, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 17, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Nov 25, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (뎅기 또는 뎅기 유사 질환 환자를 대상으로 CPCOV03의 2/3상 임상시험계획 변경승인)Nov 12, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Nov 12, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인)Nov 7, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 16, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (전립선암 치료제 CP-PCA07의 1상 임상시험계획 변경승인 신청)Oct 13, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Hyundai Bioscience / 현대바이오 / 048410 / KRX:048410
Source: KRX statistical information